AxoGen, Inc., a Florida-based company, is a leader in developing and marketing technologies for peripheral nerve regeneration and repair. The company has a global reach and offers a range of products to address the needs of patients suffering from nerve injuries. Its flagship product, the Avance Nerve Graft, is a biologically active off-the-shelf processed human nerve allograft that allows for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. In addition, the company offers the AxoGuard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves, and AxoGuard Nerve Protector, a porcine submucosa ECM product that protects damaged peripheral nerves while reinforcing nerve reconstruction and preventing soft tissue attachments. Other products include the AxoGuard Nerve Cap, a porcine submucosa ECM product that protects peripheral nerve ends and reduces the development of symptomatic or painful neuroma, and AxoTouch two-point discriminator, a tool for measuring the innervation density of the skin's surface. AxoGen, Inc. serves a broad customer base, including hospitals, surgery centers, military hospitals, and a variety of surgeons specialized in plastic reconstructive, orthopedic, and maxillofacial surgeries.